Clinical trial
OPAL - Insulin Glulisine, Diabetes Mellitus
NCT00272012
Study timeline
Study start (unknown)2004-07-01Date precision: month
Registry last updated2009-12-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus Type 2unresolved
Interventions
Insulin glulisineDRUG · verified · RxNorm: insulin glulisine, human
Sponsors & collaborators
Sanofilead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00272012 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.